| Product NDC: | 55111-681 |
| Proprietary Name: | Fondaparinux Sodium |
| Non Proprietary Name: | Fondaparinux Sodium |
| Active Ingredient(s): | 10 mg/.8mL & nbsp; Fondaparinux Sodium |
| Administration Route(s): | SUBCUTANEOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 55111-681 |
| Labeler Name: | Dr. Reddy's Laboratories Limited |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA091316 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110714 |
| Package NDC: | 55111-681-02 |
| Package Description: | 2 SYRINGE in 1 CARTON (55111-681-02) > .8 mL in 1 SYRINGE (55111-681-11) |
| NDC Code | 55111-681-02 |
| Proprietary Name | Fondaparinux Sodium |
| Package Description | 2 SYRINGE in 1 CARTON (55111-681-02) > .8 mL in 1 SYRINGE (55111-681-11) |
| Product NDC | 55111-681 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Fondaparinux Sodium |
| Dosage Form Name | INJECTION |
| Route Name | SUBCUTANEOUS |
| Start Marketing Date | 20110714 |
| Marketing Category Name | ANDA |
| Labeler Name | Dr. Reddy's Laboratories Limited |
| Substance Name | FONDAPARINUX SODIUM |
| Strength Number | 10 |
| Strength Unit | mg/.8mL |
| Pharmaceutical Classes | Factor Xa Inhibitor [EPC],Factor Xa Inhibitors [MoA] |